This is a special edition episode - Ed Tate, Director of Communications at the Hepatitis B Foundation was able to sit down with Dr. Stephan Urban the developer of the hepatitis D drug, Hepcludex. The drug, which blocks the entry of the hepatitis B and hepatitis D virus into the liver cell, was approved by the European Commission on 31 July 2020. Listen for more of their conversation.
Consider donating here to support programs like B Heppy!
Questions? Send them to: info@hepb.org
Our website: www.hepb.org
Support B Heppy!
Social Media: Instagram - Twitter - Facebook